LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. The company is based in Sandy, Utah.
LFVN Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Lifevantage Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Lifevantage Corp ranked in the 33th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Lifevantage Corp, consider:
The business' balance sheet suggests that 1% of the company's capital is sourced from debt; this is greater than merely 4.9% of the free cash flow producing stocks we're observing.
The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than only 0% of stocks in its sector (Consumer Defensive).
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Consumer Defensive that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as LFVN, try COST, INGR, MENB, CHGG, and HLF.
As part of its continued global expansion, LifeVantage Corporation (LFVN) has formally commenced business in New Zealand. Select LifeVantage products have been offered in New Zealand on a not-for-resale basis for approximately 18 months as part of the company’s Global Customer Program, helping pave the way for the company to now open for distributor enrollments as well. “New Zealand has demonstrated steady growth since opening as a customer market,” said Courtland Pearson, LifeVantage Senior Vice President of Global Field Development, Asia Pacific.
LifeVantage Corporation (LFVN) announced and launched an addition to its Protandim® line of nutrigenomic products during the company’s Elite Academy in Long Beach, Calif., over the weekend. “Our Protandim® line of synergizers is really what distinguishes us from other health and wellness companies, and we’re proud to introduce this latest breakthrough in nutrigenomic science and the newest member of the Protandim® family to the U.S. market,” said LifeVantage CEO Darren Jensen.